Epilepsy News and Research

Latest Epilepsy News and Research

FDA: Migraine prevention medicines taken during pregnancy can impact children’s IQ

The U.S. Food and Drug Administration is alerting health care providers and patients that medications including and related to valproate sodium can cause decreased IQ scores in children whose mothers took the medication during pregnancy.

7 May 2013

Clitoraid announces first annual International Clitoris Awareness Week

"Clitoraid is proud to announce its first annual International Clitoris Awareness Week, May 6 to May 12," said Nadine Gary , Clitoraid spokesperson, in a statement released today.

5 May 2013

Discovery may lead to new treatment for neurodevelopmental, neurodegenerative disorders

A key type of human brain cell developed in the laboratory grows seamlessly when transplanted into the brains of mice, UC San Francisco researchers have discovered, raising hope that these cells might one day be used to treat people with Parkinson's disease, epilepsy, and possibly even Alzheimer's disease, as well as and complications of spinal cord injury such as chronic pain and spasticity.

5 May 2013

Discovery raises hope for severe forms of human epilepsy

Epilepsy that does not respond to drugs can be halted in adult mice by transplanting a specific type of cell into the brain, UC San Francisco researchers have discovered, raising hope that a similar treatment might work in severe forms of human epilepsy.

5 May 2013

Virtual reality reveals new clues on how cells determine place

Leaving the house in the morning may seem simple, but with every move we make, our brains are working feverishly to create maps of the outside world that allow us to navigate and to remember where we are.

4 May 2013

Girls with learning, physical disabilities more likely to suffer menstrual problems

New research shows girls with learning and physical disabilities are more likely to suffer period problems compared to the general population.

3 May 2013

Study results support new view of molecules important for nerve cell signaling

National Institutes of Health researchers used the popular anti-wrinkle agent Botox to discover a new and important role for a group of molecules that nerve cells use to quickly send messages.

3 May 2013

CHOP research offers insights into epilepsy, schizophrenia, other neuropsych disorders

Medical researchers have manipulated human stem cells into producing types of brain cells known to play important roles in neurodevelopmental disorders such as epilepsy, schizophrenia and autism.

3 May 2013

Small device implanted in the brain predicts epilepsy seizures in humans

A small device implanted in the brain has accurately predicted epilepsy seizures in humans in a world-first study led by Professor Mark Cook, Chair of Medicine at the University of Melbourne and Director of Neurology at St Vincent's Hospital.

3 May 2013

NeuroSigma receives Class 2 medical device license for Monarch eTNS System from Health Canada

NeuroSigma, Inc., a California-based medical device company, today announced that it has received a Class 2 medical device license for its Monarch eTNS (external trigeminal nerve stimulation) System from Health Canada.

2 May 2013

Schizophrenia cardiovascular risk under-recognized in primary care

UK researchers have found that despite being a major contributor to premature deaths among patients with schizophrenia, cardiovascular disease is less likely to be recorded on their primary care records than those of people without schizophrenia.

30 Apr 2013

Autism linked to epilepsy drug use in pregnancy

Children born to mothers who take valproate during pregnancy are at increased risk for developing autism compared with children of women who did not take the epilepsy drug, Danish research shows.

29 Apr 2013

Targeted therapy prevents rare neurodevelopmental disorder seizures

Rapamycin treatment reduces seizure frequency and improves receptive language in patients with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome, or Pretzel syndrome, a study finds.

29 Apr 2013

Schizophrenia cardiovascular risk under-recognized in primary care

25 Apr 2013

Sirolimus effective in treating children with Pretzel syndrome, new study reports

With a better understanding of underlying mechanisms that cause a rare neurodevelopmental disorder in the Old Order Mennonite population, referred to as Pretzel syndrome, a new study reports that five children were successfully treated with a drug that modifies the disease process, minimizing seizures and improving receptive language.

25 Apr 2013

BD receives FDA approval for second prefilled injectable drug

BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD, announced today that the U.S. Food and Drug Administration has approved the second drug to be offered in the recently launched BD Simplist line of ready-to-administer prefilled generic injectables.

From BD (Becton, Dickinson and Company) 24 Apr 2013

Maternal use of valproate during pregnancy increases risk of autism in offspring

Maternal use of valproate (a drug used for the treatment of epilepsy and other neuropsychological disorders) during pregnancy was associated with a significantly increased risk of autism in offspring, according to a study in the April 24 issue of JAMA.

24 Apr 2013

Study: Stem cell transplant heals neurological deficits in mice

For the first time, human embryonic stem cells have been transformed into nerve cells that helped mice regain the ability to learn and remember.

22 Apr 2013

Research: Gene behind epilepsy syndrome could play a key role in other idiopathic epilepsies

Researchers at the University Department of Neurology at the MedUni Vienna have identified a gene behind an epilepsy syndrome, which could also play an important role in other idiopathic (genetically caused) epilepsies.

18 Apr 2013

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

The Korea-based international pharmaceutical company, SK Biopharmaceuticals, announced today the U.S. Food and Drug Administration has authorized the Investigational New Drug application for SKL15508 to treat cognitive impairment associated with schizophrenia.

18 Apr 2013

Epilepsy News and Research

Latest Epilepsy News and Research

FDA: Migraine prevention medicines taken during pregnancy can impact children’s IQ

Clitoraid announces first annual International Clitoris Awareness Week

Discovery may lead to new treatment for neurodevelopmental, neurodegenerative disorders

Discovery raises hope for severe forms of human epilepsy

Virtual reality reveals new clues on how cells determine place

Girls with learning, physical disabilities more likely to suffer menstrual problems

Study results support new view of molecules important for nerve cell signaling

CHOP research offers insights into epilepsy, schizophrenia, other neuropsych disorders

Small device implanted in the brain predicts epilepsy seizures in humans

NeuroSigma receives Class 2 medical device license for Monarch eTNS System from Health Canada

Schizophrenia cardiovascular risk under-recognized in primary care

Autism linked to epilepsy drug use in pregnancy

Targeted therapy prevents rare neurodevelopmental disorder seizures

Schizophrenia cardiovascular risk under-recognized in primary care

Sirolimus effective in treating children with Pretzel syndrome, new study reports

BD receives FDA approval for second prefilled injectable drug

Maternal use of valproate during pregnancy increases risk of autism in offspring

Study: Stem cell transplant heals neurological deficits in mice

Research: Gene behind epilepsy syndrome could play a key role in other idiopathic epilepsies

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

Everything you need to know about epilepsy eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Epilepsy News and Research

Latest Epilepsy News and Research

Everything you need to know about epilepsy eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in